Cargando…
TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549007/ http://dx.doi.org/10.1016/j.chest.2022.08.262 |
| _version_ | 1784805568323518464 |
|---|---|
| author | AHMED, MUBASHIR AYAZ HOSSAIN ESHAN, SHAYET HUSSEIN, SAMI SUN, CHENYU SANKARAN RAJAGOPALAN, KAMALNATH HUSSEIN, KHALID |
| author_facet | AHMED, MUBASHIR AYAZ HOSSAIN ESHAN, SHAYET HUSSEIN, SAMI SUN, CHENYU SANKARAN RAJAGOPALAN, KAMALNATH HUSSEIN, KHALID |
| author_sort | AHMED, MUBASHIR AYAZ |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9549007 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Chest Physicians. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95490072022-10-11 TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA AHMED, MUBASHIR AYAZ HOSSAIN ESHAN, SHAYET HUSSEIN, SAMI SUN, CHENYU SANKARAN RAJAGOPALAN, KAMALNATH HUSSEIN, KHALID Chest Chest Infection American College of Chest Physicians. Published by Elsevier Inc. 2022-10 2022-10-10 /pmc/articles/PMC9549007/ http://dx.doi.org/10.1016/j.chest.2022.08.262 Text en Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Chest Infection AHMED, MUBASHIR AYAZ HOSSAIN ESHAN, SHAYET HUSSEIN, SAMI SUN, CHENYU SANKARAN RAJAGOPALAN, KAMALNATH HUSSEIN, KHALID TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA |
| title | TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA |
| title_full | TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA |
| title_fullStr | TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA |
| title_full_unstemmed | TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA |
| title_short | TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA |
| title_sort | time to expand the use of casirivimab/imdevimab monoclonal antibody therapy? a case of compassionate use in severe covid-19 pneumonia |
| topic | Chest Infection |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549007/ http://dx.doi.org/10.1016/j.chest.2022.08.262 |
| work_keys_str_mv | AT ahmedmubashirayaz timetoexpandtheuseofcasirivimabimdevimabmonoclonalantibodytherapyacaseofcompassionateuseinseverecovid19pneumonia AT hossaineshanshayet timetoexpandtheuseofcasirivimabimdevimabmonoclonalantibodytherapyacaseofcompassionateuseinseverecovid19pneumonia AT husseinsami timetoexpandtheuseofcasirivimabimdevimabmonoclonalantibodytherapyacaseofcompassionateuseinseverecovid19pneumonia AT sunchenyu timetoexpandtheuseofcasirivimabimdevimabmonoclonalantibodytherapyacaseofcompassionateuseinseverecovid19pneumonia AT sankaranrajagopalankamalnath timetoexpandtheuseofcasirivimabimdevimabmonoclonalantibodytherapyacaseofcompassionateuseinseverecovid19pneumonia AT husseinkhalid timetoexpandtheuseofcasirivimabimdevimabmonoclonalantibodytherapyacaseofcompassionateuseinseverecovid19pneumonia |